US5922304A
(en)
|
1989-12-22 |
1999-07-13 |
Imarx Pharmaceutical Corp. |
Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
|
US6088613A
(en)
|
1989-12-22 |
2000-07-11 |
Imarx Pharmaceutical Corp. |
Method of magnetic resonance focused surgical and therapeutic ultrasound
|
US5542935A
(en)
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
US5585112A
(en)
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
US6146657A
(en)
|
1989-12-22 |
2000-11-14 |
Imarx Pharmaceutical Corp. |
Gas-filled lipid spheres for use in diagnostic and therapeutic applications
|
US5776429A
(en)
|
1989-12-22 |
1998-07-07 |
Imarx Pharmaceutical Corp. |
Method of preparing gas-filled microspheres using a lyophilized lipids
|
US6551576B1
(en)
|
1989-12-22 |
2003-04-22 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
US6001335A
(en)
|
1989-12-22 |
1999-12-14 |
Imarx Pharmaceutical Corp. |
Contrasting agents for ultrasonic imaging and methods for preparing the same
|
US5656211A
(en)
|
1989-12-22 |
1997-08-12 |
Imarx Pharmaceutical Corp. |
Apparatus and method for making gas-filled vesicles of optimal size
|
US5469854A
(en)
|
1989-12-22 |
1995-11-28 |
Imarx Pharmaceutical Corp. |
Methods of preparing gas-filled liposomes
|
US5874062A
(en)
|
1991-04-05 |
1999-02-23 |
Imarx Pharmaceutical Corp. |
Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
|
US5205290A
(en)
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
US6217849B1
(en)
|
1993-09-29 |
2001-04-17 |
Bracco Research S.A. |
Liposome suspensions as blood pool imaging contrast agents
|
US6743779B1
(en)
|
1994-11-29 |
2004-06-01 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
US5830430A
(en)
|
1995-02-21 |
1998-11-03 |
Imarx Pharmaceutical Corp. |
Cationic lipids and the use thereof
|
WO1996025955A1
(en)
*
|
1995-02-24 |
1996-08-29 |
Bracco Research S.A. |
Liposome suspensions as blood pool imaging contrast agents
|
US5997898A
(en)
|
1995-06-06 |
1999-12-07 |
Imarx Pharmaceutical Corp. |
Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
|
US6231834B1
(en)
|
1995-06-07 |
2001-05-15 |
Imarx Pharmaceutical Corp. |
Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
|
US6521211B1
(en)
|
1995-06-07 |
2003-02-18 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Methods of imaging and treatment with targeted compositions
|
US6033645A
(en)
|
1996-06-19 |
2000-03-07 |
Unger; Evan C. |
Methods for diagnostic imaging by regulating the administration rate of a contrast agent
|
US6139819A
(en)
|
1995-06-07 |
2000-10-31 |
Imarx Pharmaceutical Corp. |
Targeted contrast agents for diagnostic and therapeutic use
|
GB9519654D0
(en)
*
|
1995-09-27 |
1995-11-29 |
Nycomed Imaging As |
Stabilised phospholipid compositions
|
CA2252617A1
(en)
|
1996-05-01 |
1997-11-06 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
CN1104911C
(zh)
*
|
1996-08-02 |
2003-04-09 |
奈科姆成像有限公司 |
造影剂及其相关造影剂的改进
|
US6465016B2
(en)
*
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
US6414139B1
(en)
|
1996-09-03 |
2002-07-02 |
Imarx Therapeutics, Inc. |
Silicon amphiphilic compounds and the use thereof
|
US5846517A
(en)
|
1996-09-11 |
1998-12-08 |
Imarx Pharmaceutical Corp. |
Methods for diagnostic imaging using a renal contrast agent and a vasodilator
|
ATE231004T1
(de)
|
1996-09-11 |
2003-02-15 |
Imarx Pharmaceutical Corp |
Verbesserte verfahren zur diagnostischen bilderzeugung unter verwendung eines kontrastmittels und eines vasodilators
|
US6331286B1
(en)
|
1998-12-21 |
2001-12-18 |
Photogen, Inc. |
Methods for high energy phototherapeutics
|
GB9624918D0
(en)
*
|
1996-11-29 |
1997-01-15 |
Nycomed Imaging As |
Particulate components
|
US6090800A
(en)
|
1997-05-06 |
2000-07-18 |
Imarx Pharmaceutical Corp. |
Lipid soluble steroid prodrugs
|
US6537246B1
(en)
|
1997-06-18 |
2003-03-25 |
Imarx Therapeutics, Inc. |
Oxygen delivery agents and uses for the same
|
US6143276A
(en)
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
US6005083A
(en)
*
|
1997-03-28 |
1999-12-21 |
Neorx Corporation |
Bridged aromatic substituted amine ligands with donor atoms
|
US6416740B1
(en)
|
1997-05-13 |
2002-07-09 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Acoustically active drug delivery systems
|
US6392264B2
(en)
*
|
1997-07-08 |
2002-05-21 |
Hideki Takeuchi |
Semiconductor memory device and method of producing the same
|
US6001333A
(en)
*
|
1997-09-12 |
1999-12-14 |
See; Jackie R. |
Methods of preparing micro encapsulated agents for use in the detection of tumors by CT imaging
|
US6548047B1
(en)
|
1997-09-15 |
2003-04-15 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Thermal preactivation of gaseous precursor filled compositions
|
US8974363B2
(en)
|
1997-12-11 |
2015-03-10 |
Provectus Pharmatech, Inc. |
Topical medicaments and methods for photodynamic treatment of disease
|
US6123923A
(en)
|
1997-12-18 |
2000-09-26 |
Imarx Pharmaceutical Corp. |
Optoacoustic contrast agents and methods for their use
|
US20010003580A1
(en)
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
ATE276745T1
(de)
*
|
1998-04-09 |
2004-10-15 |
Amersham Health As |
Verwendung von teilchenförmigen kontrastmitteln in der diagnostischen bilderzeugung zur untersuchung physiologischer parameter
|
ES2216517T3
(es)
|
1998-05-29 |
2004-10-16 |
Skyepharma Canada Inc. |
Composiciones de microcapsulas termoprotegidas y procedimiento para su esterilizacion terminal con vapor.
|
US8557298B2
(en)
|
1998-08-06 |
2013-10-15 |
Provectus Pharmatech, Inc. |
Medicaments for chemotherapeutic treatment of disease
|
US20040047804A1
(en)
*
|
1998-10-29 |
2004-03-11 |
The General Hospital Corporation, A Massachusetts Corporation |
Enhanced radiation therapy
|
EP1133281A1
(de)
|
1998-11-20 |
2001-09-19 |
RTP Pharma Inc. |
Dispergierbare mit phospholipid stabilisierte mikropartikel
|
US6203778B1
(en)
|
1998-12-08 |
2001-03-20 |
The Regents Of The University Of California |
Particulate radiopaque contrast agent for diagnostic imaging and microvascular characterization
|
US20020001567A1
(en)
*
|
1998-12-21 |
2002-01-03 |
Photogen, Inc. |
Intracorporeal medicaments for high energy phototherapeutic treatment of disease
|
US8470296B2
(en)
*
|
1998-12-21 |
2013-06-25 |
Provectus Pharmatech, Inc. |
Intracorporeal medicaments for high energy phototherapeutic treatment of disease
|
US7384623B1
(en)
|
1998-12-21 |
2008-06-10 |
Provectus Pharmatech, Inc. |
High energy phototherapeutic agents
|
US6351663B1
(en)
|
1999-09-10 |
2002-02-26 |
Akorn, Inc. |
Methods for diagnosing and treating conditions associated with abnormal vasculature using fluorescent dye angiography and dye-enhanced photocoagulation
|
US6944493B2
(en)
*
|
1999-09-10 |
2005-09-13 |
Akora, Inc. |
Indocyanine green (ICG) compositions and related methods of use
|
US6443976B1
(en)
|
1999-11-30 |
2002-09-03 |
Akorn, Inc. |
Methods for treating conditions and illnesses associated with abnormal vasculature
|
KR100879702B1
(ko)
|
2000-04-12 |
2009-01-21 |
지이 헬스케어 에이에스 |
펩티드 기재 화합물
|
EP1427393A2
(de)
*
|
2000-05-02 |
2004-06-16 |
Pharmacept GmbH |
Wirkstoffhaltige liposome
|
NO20004795D0
(no)
|
2000-09-26 |
2000-09-26 |
Nycomed Imaging As |
Peptidbaserte forbindelser
|
AU2002313616A1
(en)
|
2001-07-10 |
2003-01-29 |
Amersham Health As |
Peptide-based compounds for targeting intergin receptors
|
DE60222843T2
(de)
*
|
2001-08-20 |
2008-07-17 |
Fujifilm Corporation |
Hydrophobe Iodverbindung enthaltendes Liposom und dieses enthaltendes Röntgenkontrastmittel
|
DE10148065A1
(de)
*
|
2001-09-28 |
2003-04-17 |
Max Planck Gesellschaft |
(Ester)-Lysolecithine in Liposomen
|
EP1331012A1
(de)
|
2002-01-29 |
2003-07-30 |
BRACCO IMAGING S.p.A. |
Magnetisch beeinflussbare paramagnetische Kontrastmittel für Magnetresonanzbildgebung
|
US20040022842A1
(en)
*
|
2002-06-03 |
2004-02-05 |
Mebiopharm Co., Ltd. |
Liposome preparations containing oxaliplatin
|
US20040213837A1
(en)
*
|
2002-08-05 |
2004-10-28 |
Sankaram Mantripragada |
Oil-core compositions for the sustained release of hydrophobic drugs
|
US8980310B2
(en)
*
|
2002-12-31 |
2015-03-17 |
Bharat Serums and Vaccines, Ltd. |
Non-pegylated long-circulating liposomes
|
JP2005170923A
(ja)
*
|
2003-10-21 |
2005-06-30 |
Konica Minolta Medical & Graphic Inc |
リポソーム含有x線造影剤およびその製造方法
|
CN1321697C
(zh)
*
|
2003-12-23 |
2007-06-20 |
中国人民解放军军事医学科学院毒物药物研究所 |
一种以磷脂类成分为成膜材料的超声造影剂组合物及其制备方法
|
WO2005063304A2
(en)
*
|
2003-12-24 |
2005-07-14 |
Board Of Regents, The University Of Texas_System |
Poly (l-glutamic acid) paramagnetic material complex and use as a biodegradable mri contrast agent
|
US7713517B2
(en)
*
|
2004-04-21 |
2010-05-11 |
Marval Biosciences, Inc. |
Compositions and methods for enhancing contrast in imaging
|
US8357351B2
(en)
|
2004-04-21 |
2013-01-22 |
Ananth Annapragada |
Nano-scale contrast agents and methods of use
|
WO2006009022A1
(ja)
*
|
2004-07-21 |
2006-01-26 |
Konica Minolta Medical & Graphic, Inc. |
リポソーム含有x線造影剤およびその製造方法
|
CN100427142C
(zh)
*
|
2005-01-10 |
2008-10-22 |
重庆海扶(Hifu)技术有限公司 |
一种高强度聚焦超声治疗用助剂及其筛选方法
|
CN100574811C
(zh)
*
|
2005-01-10 |
2009-12-30 |
重庆海扶(Hifu)技术有限公司 |
一种高强度聚焦超声治疗用微粒类助剂及其应用
|
CN100574809C
(zh)
*
|
2005-01-10 |
2009-12-30 |
重庆海扶(Hifu)技术有限公司 |
一种高强度聚焦超声治疗用氟碳乳剂类助剂及其应用
|
WO2006084382A1
(en)
|
2005-02-11 |
2006-08-17 |
University Health Network |
Compositions and methods for multimodal imaging
|
JP2006248978A
(ja)
|
2005-03-10 |
2006-09-21 |
Mebiopharm Co Ltd |
新規なリポソーム製剤
|
BRPI0609126A2
(pt)
*
|
2005-03-21 |
2010-02-23 |
Lifecare Innovations Pvt Ltd |
composição vesicular inter e intra multilamelar
|
RU2007140391A
(ru)
*
|
2005-04-01 |
2009-05-10 |
Дзе Борд Оф Риджентс Оф Дзе Юниверсити Оф Техас Систем (Us) |
Поли(пептид) как хелатор: способы получения и применения
|
NO20052428D0
(no)
*
|
2005-05-20 |
2005-05-20 |
Amersham Health As |
Kontrastmidler
|
NO20052429D0
(no)
*
|
2005-05-20 |
2005-05-20 |
Amersham Health As |
Konstrastmidler
|
WO2007088051A2
(en)
|
2006-01-31 |
2007-08-09 |
Bayer Schering Pharma Aktiengesellschaft |
Modulation of mdl-1 activity for treatment of inflammatory disease
|
EP2019683B2
(de)
|
2006-04-25 |
2022-08-03 |
The Regents of The University of California |
Verabreichung von wachstumsfaktoren zur behandlung von zns-erkrankungen
|
JP2009535360A
(ja)
*
|
2006-04-26 |
2009-10-01 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
高分子量神経治療薬の対流増加送達のための組成物および方法
|
WO2007129311A2
(en)
*
|
2006-05-04 |
2007-11-15 |
Pan Sci Tech S.A. |
Nano-particles with contrast agents for diagnostic delivery system for x-ray and ct
|
AU2008222678B2
(en)
*
|
2007-03-07 |
2013-01-17 |
The General Hospital Corporation |
Compositions and methods for the prevention and treatment of autoimmune conditions
|
KR100921959B1
(ko)
*
|
2007-06-04 |
2009-10-15 |
바이오스펙트럼 주식회사 |
다중층 리포좀 및 단일막 나노 리포좀을 포함하는다중-유화 베시클
|
CN104274840A
(zh)
|
2007-12-05 |
2015-01-14 |
马维尔生物科学公司 |
纳米级对比剂和使用方法
|
US20090311191A1
(en)
*
|
2008-06-13 |
2009-12-17 |
Ananth Annapragada |
Imaging of atherosclerotic plaques using liposomal imaging agents
|
US20110070294A1
(en)
*
|
2009-09-23 |
2011-03-24 |
Javeri Indu |
Methods for the Administration of Drugs Using Liposomes
|
US10143652B2
(en)
|
2009-09-23 |
2018-12-04 |
Curirx Inc. |
Methods for the preparation of liposomes
|
US9402812B2
(en)
*
|
2009-09-23 |
2016-08-02 |
Indu JAVERI |
Methods for the preparation of liposomes
|
US10894098B2
(en)
|
2012-04-09 |
2021-01-19 |
Signablok, Inc. |
Methods and compositions for targeted imaging
|
US10525152B2
(en)
|
2009-10-09 |
2020-01-07 |
Signablok, Inc. |
Methods and compositions for targeted imaging
|
US9511151B2
(en)
|
2010-11-12 |
2016-12-06 |
Uti Limited Partnership |
Compositions and methods for the prevention and treatment of cancer
|
US9801957B2
(en)
|
2011-04-06 |
2017-10-31 |
Ananth Annapragada |
Lipid-based nanoparticles
|
WO2012136813A2
(en)
|
2011-04-07 |
2012-10-11 |
Universitetet I Oslo |
Agents for medical radar diagnosis
|
EP2756459B1
(de)
|
2012-01-20 |
2020-12-09 |
Ananth Annapragada |
Verfahren und zusammensetzungen zur objektiven charakterisierung von medizinischen bildern
|
US10988516B2
(en)
|
2012-03-26 |
2021-04-27 |
Uti Limited Partnership |
Methods and compositions for treating inflammation
|
EP2833926A4
(de)
*
|
2012-04-05 |
2015-11-25 |
Univ Florida |
Neurophile nanopartikel
|
US9603948B2
(en)
|
2012-10-11 |
2017-03-28 |
Uti Limited Partnership |
Methods and compositions for treating multiple sclerosis and related disorders
|
EP2983687B1
(de)
|
2013-03-15 |
2019-09-04 |
The Regents of The University of California |
Peptide mit verminderter toxizität zur stimulation eines cholesterineffluxes
|
PT3065771T
(pt)
|
2013-11-04 |
2019-06-24 |
Uti Lp |
Metodos e composicoes para imunoterapia prolongada
|
US10258629B2
(en)
|
2014-03-28 |
2019-04-16 |
The Regents Of The University Of California |
Liposomal drug encapsulation
|
EP3204051B1
(de)
|
2014-10-08 |
2019-05-29 |
Texas Children's Hospital |
Mrt-bildgebung von amyloider plaque mittels liposomen
|
IL252705B2
(en)
|
2014-12-31 |
2023-03-01 |
Lantheus Medical Imaging Inc |
Fat-wrapped gas microsphere preparations and related methods
|
WO2016198932A2
(en)
|
2015-05-06 |
2016-12-15 |
Uti Limited Partnership |
Nanoparticle compositions for sustained therapy
|
MX2018013409A
(es)
|
2016-05-04 |
2019-07-08 |
Lantheus Medical Imaging Inc |
Métodos y dispositivos para la preparación de agentes de contraste de ultrasonido.
|
US9789210B1
(en)
|
2016-07-06 |
2017-10-17 |
Lantheus Medical Imaging, Inc. |
Methods for making ultrasound contrast agents
|
EP3412303A1
(de)
|
2017-06-08 |
2018-12-12 |
Medizinische Universität Innsbruck |
Verbessertes pharmakokinetik- und cholecystokinin-2-rezeptor (cck2r)-zielverfahren für diagnose und therapie
|
CN112138173A
(zh)
*
|
2020-10-26 |
2020-12-29 |
山东源科生物科技股份有限公司 |
一种胃肠超声造影剂及其制备方法
|
WO2023076220A1
(en)
*
|
2021-10-25 |
2023-05-04 |
Board Of Regents, The University Of Texas System |
Conjugates having antifouling nanoparticles and methods of use
|